IL42312A - Pharmaceutical formulations comprising microencapsulated ampicillin trihydrate or amoxycillin trihydrate - Google Patents
Pharmaceutical formulations comprising microencapsulated ampicillin trihydrate or amoxycillin trihydrateInfo
- Publication number
- IL42312A IL42312A IL42312A IL4231273A IL42312A IL 42312 A IL42312 A IL 42312A IL 42312 A IL42312 A IL 42312A IL 4231273 A IL4231273 A IL 4231273A IL 42312 A IL42312 A IL 42312A
- Authority
- IL
- Israel
- Prior art keywords
- trihydrate
- microcapsules
- polyvinylpyrrolidone
- ampicillin
- amoxycillin
- Prior art date
Links
- 229960003311 ampicillin trihydrate Drugs 0.000 title claims description 38
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 title description 38
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title description 34
- 239000008194 pharmaceutical composition Substances 0.000 title description 3
- 239000003094 microcapsule Substances 0.000 claims description 61
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 38
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 38
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 38
- 239000000843 powder Substances 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 29
- 239000002002 slurry Substances 0.000 claims description 28
- 239000000725 suspension Substances 0.000 claims description 17
- 238000001694 spray drying Methods 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 150000004684 trihydrates Chemical class 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 4
- MQXQVCLAUDMCEF-CWLIKTDRSA-N amoxicillin trihydrate Chemical compound O.O.O.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 MQXQVCLAUDMCEF-CWLIKTDRSA-N 0.000 claims 4
- RXDALBZNGVATNY-CWLIKTDRSA-N ampicillin trihydrate Chemical compound O.O.O.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 RXDALBZNGVATNY-CWLIKTDRSA-N 0.000 claims 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 239000007921 spray Substances 0.000 description 39
- 239000000047 product Substances 0.000 description 27
- 239000002245 particle Substances 0.000 description 19
- 239000011248 coating agent Substances 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000036515 potency Effects 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000000428 dust Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000011257 shell material Substances 0.000 description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- 229960004920 amoxicillin trihydrate Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000007907 direct compression Methods 0.000 description 2
- 231100000206 health hazard Toxicity 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920003080 Povidone K 25 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 229960003326 cloxacillin Drugs 0.000 description 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960003884 hetacillin Drugs 0.000 description 1
- DXVUYOAEDJXBPY-NFFDBFGFSA-N hetacillin Chemical compound C1([C@@H]2C(=O)N(C(N2)(C)C)[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 DXVUYOAEDJXBPY-NFFDBFGFSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical group CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical class C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/043—Drying and spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
- B01J13/125—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution by evaporation of the solvent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2357672A GB1403584A (en) | 1972-05-19 | 1972-05-19 | Control medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL42312A0 IL42312A0 (en) | 1973-07-30 |
| IL42312A true IL42312A (en) | 1977-01-31 |
Family
ID=10197917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL42312A IL42312A (en) | 1972-05-19 | 1973-05-18 | Pharmaceutical formulations comprising microencapsulated ampicillin trihydrate or amoxycillin trihydrate |
Country Status (16)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1403584A (en) * | 1972-05-19 | 1975-08-28 | Beecham Group Ltd | Control medicaments |
| GB1532993A (en) * | 1975-03-07 | 1978-11-22 | Beecham Group Ltd | Injectable antibiotic compositions |
| JPS5446001U (enrdf_load_stackoverflow) * | 1977-09-07 | 1979-03-30 | ||
| FR2403080A1 (fr) * | 1977-09-15 | 1979-04-13 | Heyden Chem Fab | Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication |
| DE2805106A1 (de) * | 1978-02-07 | 1979-08-16 | Hoechst Ag | Mikrokapseln aus polyvinylalkohol mit fluessigem, wasserunloeslichem fuellgut und verfahren zu deren herstellung |
| JPS56156214A (en) * | 1980-05-02 | 1981-12-02 | Yoshiaki Kawashima | Preparation of tableting enteric microcapsule |
| JPS5867616A (ja) * | 1981-10-15 | 1983-04-22 | Tanabe Seiyaku Co Ltd | 腸溶性マイクロカプセル |
| US4370313A (en) * | 1981-10-26 | 1983-01-25 | Eaton Laboratories, Inc. | Nitrofurantoin dosage form |
| HU187215B (en) * | 1983-01-26 | 1985-11-28 | Egyt Gyogyszervegyeszeti Gyar | Method for producing pharmaceutical product of high actor content and prolonged effect |
| SE8404808L (sv) * | 1983-10-03 | 1985-04-04 | Avner Rotman | Mikrokapslat lekemedel i sot matris |
| IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| JPS61218516A (ja) * | 1985-03-25 | 1986-09-29 | Ichimaru Fuarukosu Kk | 徐放性マイクロカプセルの製造法 |
| IT1230095B (it) * | 1989-04-27 | 1991-10-05 | Parenta Srl | Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici. |
| DE69016788T2 (de) * | 1990-11-29 | 1995-06-22 | Faulding F H & Co Ltd | Verfahren zur Herstellung von Flüssigkeiten enthaltenden Pulvern. |
| SE9903236D0 (sv) * | 1999-09-10 | 1999-09-10 | Astra Ab | Method to obtain microparticles |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7112083A (enrdf_load_stackoverflow) * | 1970-09-16 | 1972-03-20 | ||
| GB1403584A (en) * | 1972-05-19 | 1975-08-28 | Beecham Group Ltd | Control medicaments |
-
1972
- 1972-05-19 GB GB2357672A patent/GB1403584A/en not_active Expired
-
1973
- 1973-05-15 IE IE775/73A patent/IE37637B1/xx unknown
- 1973-05-17 DK DK277173AA patent/DK134424B/da unknown
- 1973-05-18 BE BE131326A patent/BE799783A/xx unknown
- 1973-05-18 FR FR7318155A patent/FR2185390B1/fr not_active Expired
- 1973-05-18 ES ES414908A patent/ES414908A1/es not_active Expired
- 1973-05-18 NL NL7307033A patent/NL7307033A/xx unknown
- 1973-05-18 HU HUBE1170A patent/HU167559B/hu unknown
- 1973-05-18 CA CA171,807A patent/CA1025359A/en not_active Expired
- 1973-05-18 AT AT439473A patent/AT337902B/de not_active IP Right Cessation
- 1973-05-18 IL IL42312A patent/IL42312A/en unknown
- 1973-05-18 DE DE2325410A patent/DE2325410A1/de active Pending
- 1973-05-19 JP JP48056245A patent/JPS4954518A/ja active Pending
- 1973-05-21 ZA ZA00733406A patent/ZA733406B/xx unknown
- 1973-05-21 AR AR248141A patent/AR197900A1/es active
- 1973-05-21 AU AU55965/73A patent/AU475493B2/en not_active Expired
- 1973-08-16 JP JP48092341A patent/JPS49116220A/ja active Pending
-
1974
- 1974-04-05 DK DK190774A patent/DK134423C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK134423B (da) | 1976-11-08 |
| FR2185390B1 (enrdf_load_stackoverflow) | 1977-04-15 |
| DK134424B (da) | 1976-11-08 |
| AT337902B (de) | 1977-07-25 |
| IE37637L (en) | 1973-11-19 |
| NL7307033A (enrdf_load_stackoverflow) | 1973-11-21 |
| IE37637B1 (en) | 1977-09-14 |
| AR197900A1 (es) | 1974-05-15 |
| FR2185390A1 (enrdf_load_stackoverflow) | 1974-01-04 |
| HU167559B (enrdf_load_stackoverflow) | 1975-11-28 |
| ES414908A1 (es) | 1976-06-01 |
| CA1025359A (en) | 1978-01-31 |
| JPS4954518A (enrdf_load_stackoverflow) | 1974-05-27 |
| DE2325410A1 (de) | 1973-11-29 |
| GB1403584A (en) | 1975-08-28 |
| AU5596573A (en) | 1974-11-21 |
| ATA439473A (de) | 1976-11-15 |
| DK134423C (da) | 1977-04-12 |
| BE799783A (fr) | 1973-11-19 |
| DK134424C (enrdf_load_stackoverflow) | 1977-05-23 |
| AU475493B2 (en) | 1976-08-26 |
| JPS49116220A (enrdf_load_stackoverflow) | 1974-11-06 |
| DK190774A (da) | 1975-10-06 |
| ZA733406B (en) | 1975-03-26 |
| IL42312A0 (en) | 1973-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4016254A (en) | Pharmaceutical formulations | |
| IL42312A (en) | Pharmaceutical formulations comprising microencapsulated ampicillin trihydrate or amoxycillin trihydrate | |
| US20200016082A1 (en) | Improved Spray Drying Process for Production of Powders with Enhanced Properties | |
| US5260306A (en) | Inhalation pharmaceuticals | |
| Davies et al. | Batch production of pharmaceutical granulations in a fluidized bed I: effects of process variables on physical properties of final granulation | |
| RU2529798C2 (ru) | Способ получения лекарственных соединений, содержащих дабигатран | |
| RU2166936C2 (ru) | Способ получения дозировочных единиц путем мокрой грануляции | |
| DK159716B (da) | Inhalationspulver, fremgangsmaade til fremstilling heraf og farmaceutisk formulering indeholdende et saadant | |
| WO1992018106A1 (en) | Method of manufacturing solid dispersion | |
| EP0490648A1 (en) | Pharmaceutical agents | |
| JP2002542025A (ja) | 噴霧乾燥方法及びその装置並びに該方法により得られる微粒子材料 | |
| NO171826B (no) | Fremgangsmaate for fremstilling av et stabilt nicorandilholdig preparat | |
| US5720439A (en) | High speed agitated granulation method and high speed agitated granulating machine | |
| KR960015137B1 (ko) | 안정화된 사료 첨가제 및 이의 제조방법 | |
| JPH06192113A (ja) | 生薬類の造粒方法および固形製剤 | |
| EP0436373B1 (en) | Process for making tablets containing spray-dried naproxen or naproxen sodium | |
| JPH07507230A (ja) | 粉末材料からのグラニュールの製造方法及び装置 | |
| EP0040472A2 (en) | Spray dried N-acetyl-p-aminophenol compositions and method for manufacture thereof | |
| KR19990077775A (ko) | 저전단 과립화법을 사용하여 투여 단위를 제조하는 방법 | |
| JP2019520202A (ja) | 粒子状材料の製造方法 | |
| Shankar et al. | Pelletization: a most significant technology in the pharmaceuticals | |
| US5160469A (en) | Manufacture of pellets of xanthine derivatives | |
| EP1968523A1 (en) | A plant and a process for production of tablets | |
| CA2009090C (en) | Process for producing solid pharmaceutical preparations | |
| JP2000290183A (ja) | リボフラビン顆粒またはリボフラビン微小顆粒の製造方法、該顆粒または微小顆粒、それらの使用およびそれらを含有する錠剤 |